/ 2 2.4 BRIDGED SPIRO2.4HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS

摘要

The present invention relates to a bridged spiro [2.4] heptane derivative of formula (I) and to its preparation as a pharmaceutically active compound as an ALX receptor and / or FPRL2 agonist for the treatment of inflammatory and obstructive airways diseases and its use. Wherein W, Y, Z, R ¹ And R ² are as defined in the above description.